BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22362822)

  • 1. Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.
    Davis TM; Peters KE; Bruce DG; Davis WA
    J Clin Endocrinol Metab; 2012 May; 97(5):1581-8. PubMed ID: 22362822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and precipitants of hospitalization for pancreatitis in people with diabetes: the Fremantle Diabetes Study.
    Davis TM; Drinkwater J; Davis WA
    Diabet Med; 2014 Aug; 31(8):913-9. PubMed ID: 24661305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study.
    Marschall HU; Wikström Shemer E; Ludvigsson JF; Stephansson O
    Hepatology; 2013 Oct; 58(4):1385-91. PubMed ID: 23564560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the fremantle diabetes study.
    Hamilton EJ; Martin N; Makepeace A; Sillars BA; Davis WA; Davis TM
    PLoS One; 2013; 8(3):e60502. PubMed ID: 23536910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study.
    Magliano DJ; Davis WA; Shaw JE; Bruce DG; Davis TM
    Eur J Endocrinol; 2012 Oct; 167(4):589-99. PubMed ID: 22893694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.
    Nkontchou G; Cosson E; Aout M; Mahmoudi A; Bourcier V; Charif I; Ganne-Carrie N; Grando-Lemaire V; Vicaut E; Trinchet JC; Beaugrand M
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2601-8. PubMed ID: 21752887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes.
    Harman DJ; Kaye PV; Harris R; Suzuki A; Gazis A; Aithal GP
    Hepatology; 2014 Jul; 60(1):158-68. PubMed ID: 24585431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.
    Bhardwaj S; Canlas K; Kahi C; Temkit M; Molleston J; Ober M; Howenstine M; Kwo PY
    J Clin Gastroenterol; 2009 Oct; 43(9):858-64. PubMed ID: 19525864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia complicating type 2 diabetes and the influence of premature mortality: the Fremantle Diabetes Study.
    Bruce DG; Davis TME; Davis WA
    Acta Diabetol; 2019 Jul; 56(7):767-776. PubMed ID: 30945048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
    Myhill P; Davis WA; Bruce DG; Mackay IR; Zimmet P; Davis TM
    Diabet Med; 2008 Oct; 25(10):1245-50. PubMed ID: 19046207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study.
    Hamilton E; Davis WA; Bruce DG; Davis TM
    J Clin Endocrinol Metab; 2017 Feb; 102(2):551-559. PubMed ID: 27880070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based cohort.
    Lin CC; Chiang JH; Li CI; Hsieh TF; Liu CS; Lin WY; Lee YD; Li TC
    Br J Cancer; 2014 Nov; 111(11):2180-6. PubMed ID: 25275365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study.
    Davis WA; Bruce DG; Davis TM
    Diabetologia; 2007 Mar; 50(3):510-5. PubMed ID: 17237940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of diabetic complications in fibrocalculous pancreatic diabetic patients and type 2 diabetic patients: a cross-sectional comparative study.
    Kanta Barman K; Padmanabhan M; Premalatha G; Deepa R; Rema M; Mohan V
    J Diabetes Complications; 2004; 18(5):264-70. PubMed ID: 15337499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and determinants of carpal tunnel decompression surgery in type 2 diabetes: the Fremantle Diabetes Study.
    Makepeace A; Davis WA; Bruce DG; Davis TM
    Diabetes Care; 2008 Mar; 31(3):498-500. PubMed ID: 18070996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.
    Morgan CL; Jenkins-Jones S; Currie CJ; Rees DA
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3251-60. PubMed ID: 22767635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
    Trombetta M; Spiazzi G; Zoppini G; Muggeo M
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of hospitalization for tendon rupture in type 2 diabetes: the Fremantle diabetes study.
    Zakaria MH; Davis WA; Davis TM
    Diabet Med; 2014 Apr; 31(4):425-30. PubMed ID: 24151882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.